Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. revenue for the last year amounted to 9.64 B EUR, the most of which — 6.78 B EUR — came from its highest performing source at the moment, Big Business, the year earlier bringing 6.86 B EUR. The greatest contribution to the revenue figure was made by China — last year it brought Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. 9.64 B EUR, and the year before that — 9.84 B EUR.